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ABSTRACTSConclusion: The results were accessible, useable and reliable, shown by
the LIDA tool. The information required a high level of education, shown by
the Gunning-Fog Index and Flesch Readability Score.
The best three websites for patient self-education about mitral valve
replacement are: http://www.drugs.com/cg/mitral-valve-replacement-
inpatient-care.html, http://www.nhs.uk/conditions/Aorticvalvereplace
ment/Pages/Whatisitpage.aspx, http://www.bhf.org.uk/heart-health/
treatments/valve-heart-surgery.aspx0683: STARTING & EVALUATING A ROBOT-ASSISTED VATS PROGRAMME:
PILOT PHASE
Sandra Gelvez-Zapata, Maral Rouhani, Rachel Kuo, Priya Sastry,
Aman S. Coonar. Papaworth Hospital, Cambridge, UK.
Aim: The Freehand TM robot scope holder has been recently released. We
sought to assess the feasibility of implementing and using this robot-
assisted telescope holder in VATS. This is ﬁrst use in thoracic surgery.
Methods: Following dry-lab training of the consultant and theatre team by
an experienced trainer we introduced the system into the operating room.
Non-lobectomy patients were considered for robot-assisted VATS (R-
VATS). 27 consecutive VATS patients were selected. 22 procedures were
completed by R-VATS. The procedures were 9 wedge resections, 7 pneu-
mothorax, 2 lung volume resections (LVRS), 3 empyema and 1 pleurectomy
for mesothelioma.
Results: Surgical time (including on table-robot positioning): 50 - 115 min
(mean 82). Total operating room time (including robot set-up/take down):
65 - 140min (mean 111). R-VATcases by consultant with assistant available
but hands-off: 21/22. R-VAT cases by trainee with consultant scrubbed:1/
22
Conclusions: Dry-lab preparation allowed robot position to be optimized.
Implementation was rapid and safe. Consideration of robot placement and
port position is critical. The robot gave a stable, non-wandering view.
Assistants observed the procedure, but were not required to participate.
Since these procedures can be conducted by a single operator there are
manpower implications. Operative and theatre times are acceptable.0801: THERMO-REACTIVE CLIPS DO NOT PREVENT STERNAL WOUND
INFECTION IN OBESE PATIENTS AFTER CARDIAC SURGERY
Clare Burdett, Simon Kendall, Joel Dunning, Andrew Owens,
Andrew Goodwin, Steve Hunter, Jonathan Ferguson, Tracey Smailes,
Cheng-Hon Yap, Enoch Akowuah. James Cook University Hospital,
Middlesbrough, UK.
Aim:We have previously advocated using thermo-reactive clips (TR-clips)
for reducing deep sternal wound infection (DSWI) after median sternot-
omy. We analyzed our data to clarify whether a beneﬁt existed in obese
patients.
Methods: We retrospectively reviewed our institutional database of pa-
tients who underwent cardiac surgery. All patients with a BMI ¼/>30
between 2008-2011 were included.
Results: 847 patients -66% had sternal closure with TR-clips and 34% with
sternal wires. Pre-operative demographics and risk factors for sternal
wound infection were similar except a greater proportion of men received
TR-clips (74% vs 62% p¼<0.001).
There was no difference in the rate of superﬁcial wound infections (4.5%
TR-clips vs 3.4% wires p¼0.58). However, the incidence of DSWI was
greater (TR-clips 3.6% vs wires 1% p¼0.04). The rate of repeat surgery to
treat DSWI was also higher (TR-clips 1.6% vs 0% p¼0.03). Multivariate
analysis showed TR-clips to be an independent predictor of DSWI eodds
ratio 3.88: 95% CI 1.07-14.07 (p¼0.03). Propensity score matching of the
two groups (to account for baseline differences) resulted in 263 patients
per group. Once matched, there was no difference in the rate of any sternal
wound infection.
Conclusions: In obese patients TR-clips do not prevent sternal wound
infection.0805: A SURVEY OF THE MANAGEMENT OF POST-OPERATIVE ATRIAL
FIBRILLATION IN CARDIAC CENTRES ACROSS THE UK
Clare Burdett. Cardiothoracic Trainees Research Collaborative, CTRC, UK.
Aim: European guidelines have been written on the management of post-
op atrial ﬁbrillation (AF). We sought to determine the variability inpractice of post-op AF management in cardiac surgical centres across
the UK.
Method: 32 centres responded to a questionnaire survey on post-op AF
management following conventional cardiac surgery. Results were
collated and analysed.
Results: Only 9 (28%) units had a formal written policy. A further 17 (53%)
felt an ‘unofﬁcial’ unit policy existed. 6 (19%) units used surgeon speciﬁc
preferences. Where a formal policy existed all but one centre used Amio-
darone 1st line. Sotalol was the most common alternative in units where
individual surgeons differed in practice. Regularly encountered medica-
tions were Amiodarone, Sotalol, Bisoprolol and Digoxin. Overall 13
different medications were cited.
DC cardioversion was used at all centres in cases of haemodynamic
instability. At some centres it was used for stable non-responders to
medical therapy but timing varied greatly (1-5 days). Requirement for
anticoagulation or transoesophageal echo to exclude LV thrombus was
variable between units.
Conclusions: In the UK management of post-op AF varies between and
within units. There may be beneﬁts from formalization of unit policies to
reduce variability and ensure current best practice is followed.0889: CABG & SURGICAL INFECTION. OBSERVATIONS FROM A SCOTTISH
CARDIOTHORACIC UNIT
Umberto Pisano, Robert Jeffrey, George Gibson. Cardiothoracic Department,
Aberdeen, UK.
Objective: To audit the rate of surgical wound infection after coronary
artery bypass surgery and compare it with latest literature.
Method: Retrospective analysis of signicant sample of patients who un-
derwent coronary artery bypass graft (CABG) from January 2011 to January
2012.
Results: A statistically signiﬁcant sample was taken from a pool of 317
patients operated during the above interval. To achieve a 95% CI, 174 notes
were randomly screened and possible risk factors for surgical infection
evaluated. Both sternal wound and the graft donor site were taken into
account for rate of surgical site infection (SSI). The presence of diabetes or
chronic kidney disease did not confer increased risk of SSI, while a history
of cancer within previous 5 years from surgery and a documented acute
kidney injury in the post-operative period carried increased risk of SSI, as
independent risk factors.
Conclusions: The rate of SSI after CABG in our department is estimated as
3.4% for the sternal site and 4.6% for the donor site. The rate of deep sternal
infection is 1.7%. Post-operative renal injury was correlated with SSI,
possibly indirectly, determining increased length of hospital admission.
Second generation cephalosporins remain a valid choice in cardiac surgery
antibiotic prophylaxis.0929: AUDITING COMPLIANCE WITH ANTICOAGULATION GUIDELINES
AFTER HEART VALVE SURGERY
John Massey, Georgios Maniakis-Grivas, Danai Karamanou, Nigel Drury.
Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Aim: Following heart valve surgery, patients often require life-long anti-
coagulation and local & national guidelines have been published. An
ongoing audit was conducted to assess compliance with these guidelines
and the accuracy of discharge documentation.
Method: During each cycle, data was collected from the local PATS data-
base on 100 consecutive patients undergoing valve surgery. The standard
was 100% compliance with guidelines and accuracy of documentation was
assessed for anticoagulation therapy, duration and INR. The audit was
presented at local Clinical Governance meetings and action plans
implemented.
Results: First cycle (2009): 80% patients were treated according to
guidelines and 82% had accurate documentation. Subsequently, guidelines
were included in the junior doctor induction and the need for accurate
documentation emphasised. Second cycle (2010): 90% followed guidelines
and 78% of discharge summaries were accurate. Recommendations
included incorporating a drop-down box into the electronic discharge and
displaying a guidelines poster in the junior doctors' ofﬁce. Third cycle
(2012): 81% followed guidelines with 93% accuracy of discharge sum-
maries. 9% patients were treated with antiplatelet therapy rather than
warfarin after mitral repair.
